Servier, the parent company of Biogaran, is actively considering offers for the French generic drug leader. Olivier Laureau, president of Servier, confirmed the company's openness to acquisition proposals. This comes amidst a leadership change at Biogaran, with Guillaume Recorbet appointed as the new CEO. The ongoing discussions about a potential sale indicate Servier's strategic interest in exploring options for Biogaran's future.